Evofem Biosciences, Inc. (EVFM) › Net IncomeEvofem Biosciences, Inc. (EVFM) — Net IncomeAnnual figures by fiscal year, from SEC filings.2013: -$15.02M2014: -$10.82M2015: -$43.16M2016: -$13.02M2017: -$105.31M2018: -$125.71M2019: -$80.03M2020: -$142.31M2021: -$205.19M2022: -$76.70M2023: $52.98M2024: -$8.86M2025: $391.0K$391.0K2013Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$391.0K+104.4%2024-$8.86M-116.7%2023$52.98M+169.1%2022-$76.70M+62.6%2021-$205.19M-44.2%2020-$142.31M-77.8%2019-$80.03M+36.3%2018-$125.71M-19.4%2017-$105.31M-708.9%2016-$13.02M+69.8%2015-$43.16M-298.9%2014-$10.82M+27.9%2013-$15.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share